CNBC February 4, 2025
Happy Tuesday! Most people quit a highly popular class of weight loss and diabetes drugs called GLP-1s within a year of starting them, several studies have shown.
But new research has more details on who is more likely to stay on the pricey drugs, which cost roughly $1,000 per month before insurance and other rebates. Many insurance plans cover GLP-1s for diabetes, but not for obesity.
Around 65% of patients without diabetes discontinued GLP-1s in less than one year, according to a study published Friday in JAMA Network Open, a medical journal. Those with Type 2 diabetes were less likely to quit the drugs within a year, at about 46%.
Those rates were around 84% vs 64%,...
Today's Sponsors
Today's Sponsor